Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Medifast (MED) over the last 16 years, with Q4 2025 value amounting to $167.3 million.

  • Medifast's Cash & Current Investments rose 303.61% to $167.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $167.3 million, marking a year-over-year increase of 303.61%. This contributed to the annual value of $167.3 million for FY2025, which is 303.61% up from last year.
  • As of Q4 2025, Medifast's Cash & Current Investments stood at $167.3 million, which was up 303.61% from $173.5 million recorded in Q3 2025.
  • Medifast's 5-year Cash & Current Investments high stood at $212.9 million for Q1 2021, and its period low was $61.1 million during Q2 2022.
  • In the last 5 years, Medifast's Cash & Current Investments had a median value of $158.8 million in 2021 and averaged $146.0 million.
  • As far as peak fluctuations go, Medifast's Cash & Current Investments crashed by 6906.76% in 2022, and later soared by 14137.45% in 2023.
  • Quarter analysis of 5 years shows Medifast's Cash & Current Investments stood at $109.5 million in 2021, then dropped by 19.95% to $87.7 million in 2022, then skyrocketed by 71.1% to $150.0 million in 2023, then grew by 8.2% to $162.3 million in 2024, then grew by 3.04% to $167.3 million in 2025.
  • Its Cash & Current Investments stands at $167.3 million for Q4 2025, versus $173.5 million for Q3 2025 and $162.7 million for Q2 2025.